Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 14Terminated 3Unknown 2Withdrawn 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 25Gastrointestinal 4Genitourinary 3Thoracic 1Plasma cell 1NET 1Head & Neck 1Gynecologic 1Endocrine 1CNS 1

Conditions

Ovarian Neoplasms 513Uterine Cervical Neoplasms 366Endometrial Neoplasms 311Breast Neoplasms 131Colorectal Neoplasms 116Neoplasms 98Fallopian Tube Neoplasms 90Carcinoma, Non-Small-Cell Lung 88Stomach Neoplasms 85Pancreatic Neoplasms 81Lung Neoplasms 73Prostatic Neoplasms 69Melanoma 68Carcinoma, Ovarian Epithelial 66Neoplasm Metastasis 62Triple Negative Breast Neoplasms 52Vulvar Neoplasms 50Squamous Cell Carcinoma of Head and Neck 49Head and Neck Neoplasms 45Esophageal Neoplasms 44Peritoneal Neoplasms 41Uterine Neoplasms 40Urinary Bladder Neoplasms 40Carcinoma, Hepatocellular 35Carcinoma, Renal Cell 34Papillomavirus Infections 33Uterine Cervical Dysplasia 31Colonic Neoplasms 31Sarcoma 30Vaginal Neoplasms 28

Interventions

Injections 1Ifosfamide 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Liposarcoma × Gynecologic × Clear all
NCT06277154 2025-07-24

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

HRYZ Biotech Co.

Phase 2 Recruiting
148 enrolled
GynecologicSarcoma

Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Endometrial Stromal, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡